Results 21 to 30 of about 8,625 (250)

Congenital factor VII deficiency: Multidisciplinary approach is the key to successful perioperative outcome [PDF]

Indian Journal of Anaesthesia, 2017
Sushama Raghunath Tandale, Sunita M Khedkar, Aparna Hemraj Yadav, Shivankar Ajatshatru   +3 more
doaj   +2 more sources

Treatment of Congenital Factor VII Deficiency with a New Concentrate [PDF]

Thrombosis and Haemostasis, 1977
A commercial factor VII concentrate, made from ACD plasma by a process involving successive adsorptions of cryoprecipitate supernatant on DEAE Sephadex and of the resulting supernatant on A1(0H)3 was administered to 10 patients with severe factor VII deficiency.5 patients received only one dose for treatment of single bleeding episodes, the remaining 5
G. Mariani, P. M. Mannucci, MAZZUCCONI, Maria Gabriella, A. Capitanio   +3 more
openaire   +3 more sources

Anesthetic management of a patient with factor VII deficiency undergoing laparoscopic colectomy: a case report

JA Clinical Reports, 2016
Background Congenital factor VII (FVII) deficiency is a rare autosomal recessive coagulation disorder that is characterized by prolongation of prothrombin time.
Akari Yoshida, Yoshiki Kimoto, Kanako Ejiri, Yasuyuki Mitani, Tomoyuki Kawamata   +4 more
doaj   +1 more source

Brief Overview about Inherited Rare coagulation disorders [PDF]

Zagazig University Medical Journal
Background: Numerous rare congenital bleeding disorders include fibrinogen and prothrombin deficiency as well as factor (V, VII, VIII, XI, X, and XIII) deficiency.
Laila Sherief, Marwa Zakaria, Ahmed Abd El Fattah, Mona Hamed   +3 more
doaj   +1 more source

AryoSeven RT (Coagulation factor VIIa, recombinant) safety and efficacy study among congenial factor VII deficient patients in Iraq

Iraqi Journal of Hematology, 2022
BACKGROUND: Recombinant activated factor VII (FVII) is a product onetime evolved to stop bleeding occurring in hemophilia A and B patients with inhibitor, congenital FVII deficiency, Glanzmann disease, and in life-threatening bleeding.
Nidal Karim Al-Rahal, Ahmed Shemran Alwataify, Safa Mohammed Shawkat, Israa Almusawi, Azeezah Mohammed Mohsin   +4 more
doaj   +1 more source

Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII

The Turkish Journal of Pediatrics, 2018
Intracranial hemorrhage is considered the most common cause of death in newborns with congenital factor VII (FVII) deficiency. Recombinant activated FVII (rFVIIa) provides specific replacement therapy, however there is limited experience with its ...
Zeynep İnce, Özgül Bulut, Melike Tuğrul-Aksakal, Ayşegül Ünüvar, Ömer Devecioğlu, Asuman Çoban   +5 more
doaj   +1 more source

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN‐Digenic Myopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective SRPK3/TTN‐digenic myopathy was recently established as a skeletal muscle myopathy caused by digenic inheritance. This study characterizes the early clinical presentation of SRPK3/TTN‐digenic myopathy in one previously reported and seven newly identified pediatric patients.
Rotem Orbach, Sandra Donkervoort, Carola Hedberg‐Oldfors, Giovanni Baranello, Dimah Saade, Precilla D'Souza, Ruchee Patel, Eva Michael, A. Reghan Foley, Diana Bharucha‐Goebel, S. Jin Haugland, Meghan McAnally, Omer Abdul Hamid, Katherine Chao, Ellen F. Macnamara, Alan H. Beggs, Anna Sarkozy, Juliane Mueller, Steven A. Moore, Richard S. Finkel, Cynthia J. Tifft, Francesco Muntoni, Anders Oldfors, Carsten G. Bönnemann   +23 more
wiley   +1 more source

Managing dual risks: percutaneous coronary revascularization in congenital factor VII deficiency [PDF]

Българска кардиология
Factor VII defi ciency is a rare inherited coagulation disorder characterized by decreased activity of factor VII, leading to variable bleeding tendencies that may not correlate with measured FVII levels. While many patients remain asymptomatic,
G. Goranov, V. Doktorova, V. Goranova-Marinova   +2 more
doaj   +3 more sources

Congenital Deficiency of Factor VII in a Canine Family

Experimental Animals, 1987
Prolonged prothrombin time in the blood coagulation test was seen in some beagle dogs whose activated partial prothrombin times were distributed within the normal range. This phenomenon suggested possible abnormalities in coagulation factors II, V, VII, and/or X.
M, Noguchi, T, Fujii, A, Michizono
openaire   +3 more sources

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source